Instituto de Medicina Molecular
Ana Roque serves as a Research Project Manager at Instituto de Medicina Molecular, specializing in infectious diseases and oncology through various research initiatives. With a comprehensive background in clinical research, Ana has held roles such as Project Manager at CTI Clinical and Consulting Services, and Senior Clinical Research Associate at IQVIA, where clinical studies in multiple therapeutic areas were managed. Previous experience includes leadership in global clinical trials at AstraZeneca and postdoctoral research at Universidade de Aveiro focusing on biomaterials for regenerative medicine. Ana’s academic qualifications include a Doctor of Philosophy in Molecular and Cell Biology and several master's degrees in related fields, complemented by an Executive Master's in Project and Program Management.
This person is not in any offices
Instituto de Medicina Molecular
WEBSITE: imm.medicina.ulisboa.pt FACEBOOK: www.facebook.com/immolecular TWITTER: www.twitter.com/immolecular The mission of Instituto de Medicina Molecular (IMM) is to foster basic, clinical and translational biomedical research with the aim of contributing to a better understanding of disease mechanisms, developing novel predictive tests, improving diagnostics tools and developing new therapeutic approaches. Located on the campus of the Faculty of Medicine of the University of Lisbon, IMM is a Laboratory Associated to the National Ministry of Science and Higher Education. IMM is mainly supported by national public funds and European Union funds. The research expenditure is also supported by funds obtained from peer reviewed competitive grants, private donations and industrial partnerships. The Academic Medical Centre of Lisbon created as a consortium, brings together IMM, Faculty of Medicine of the University of Lisbon and the Hospital de Santa Maria with the aim of developing an integrated view of medicine, encouraging a crosswise biomedical research both in academic laboratories and clinical practice.